← FDA Drug Approvals (Drugs@FDA)
SUMATRIPTAN AND NAPROXEN SODIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARM · Approved 2018-07-20
Drug application
- FDA Application #
ANDA202803- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SUMATRIPTAN AND NAPROXEN SODIUM
- Generic name
- SUMATRIPTAN AND NAPROXEN SODIUM
- Active ingredients
- NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SUN PHARM
- Manufacturer
- NorthStar RxLLC
- First approval
- 2018-07-20
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown